1. Home

Drugs

The Center for Drug Evaluation and Research (CDER) ensures that safe and effective drugs are available to improve the health of the people in the United States

Topic Paragraphs
Digital Illustration of circuitry with floating panels containing code

FDA launches new adverse event look-up tool

As part of a commitment to modernization and transparency, the agency is offering direct access to product safety data. All submitted reports are now consolidated into one streamlined, user-friendly dashboard for scientists, researchers, and the public.

Learn more
Consumer Contact Information Drug Alerts and Statements What's New Related to Drugs

Search our databases:

Drugs@FDA

Find information about most FDA-approved prescription, generic, and over-the-counter drug products.

Drug Shortages

Find information about drug shortages caused by manufacturing and quality problems, delays, and discontinuations.

Orange Book

The Orange Book identifies drug products approved by FDA on the basis of safety and effectiveness.

News

Graphic with a light blue and white background. There is a text overlay reading Public Meeting, April 23, 2026

FDA to hold meeting about increasing access to nonprescription drugs

Public meeting will focus on opportunities to improve access

A photo collage displaying seven different bottles and boxes of dietary supplements labeled in Spanish. The products shown include Kuka Flex CBD, Curcuflex, Umary, Yeicob, and RM Joe.
Pictured are some of the hyaluronic acid products found to contain hidden drug ingredients. Using these unapproved products can lead to severe health issues and hospitalization.

Hidden ingredients pose risks in some hyaluronic acid products

Using the unapproved products can lead to severe health issues and hospitalization
A scientist wearing a lab coat, face mask, and safety goggles holds a test tube and pipette. The image is overlaid with glowing blue graphics of a DNA double helix and other scientific data visualizations.
This year marks the 30th anniversary of the U.S. Food and Drug Administration’s Office of Clinical Pharmacology.

Office of Clinical Pharmacology 2025 annual report now available

Report outlines achievements and activities in science and innovation

Navigate the Drugs Section

Center

Upcoming Drug-related Events

Priority Areas & Initiatives

Opioids

Reducing the impact of opioid misuse and abuse

Generics

Ensuring access to safe, affordable, and effective generic drugs

Warning Letters

Warning and Notice of Violation Letters to Pharmaceutical Companies

Guidances

FDA's current thinking on drug development and review activities

Drug Shortages

Search the database, learn about root causes and potential solutions

Resources

Information for consumers, health professionals, and industry

CENTER FOR DRUG EVALUATION AND RESEARCH

druginfo@fda.hhs.gov

Toll Free
(855) 543-3784
(301) 796-3400

Hours Available

Center for Drug Evaluation and Research (CDER)

Paragraph Header (Column 2)
FOR UPDATES ON X FOLLOW

@FDA_Drug_Info

Your source for the latest drug information.
Know the moment it happens.

Back to Top